Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Method

Supplier evaluation rubric

The six weighted criteria, the anchored zero-to-five scale, and what the resulting score does and does not mean.

The Institute assesses documentation, not product. It has purchased nothing, tested nothing and inspected nothing. Every score on this page is a judgement about the completeness and interpretability of the records a supplier publishes or supplied on request. A high score means that a supplier documents its material well. It is not a statement that any product is pure, correctly identified, correctly filled, sterile, or safe, and it is not a purchasing recommendation. The Institute makes no purchasing recommendations.

§1What the rubric measures

The rubric measures the completeness and interpretability of the records a supplier publishes or supplies on request. It does not measure product quality, and the Institute has not measured product quality for any supplier in its set.

The relationship between documentation quality and product quality is plausible and unmeasured. A supplier that reports a purity figure with its method, a peptide content against a named standard, a water determination and a counter-ion determination has supplied enough information for a purchaser to know what they received. A supplier that reports a bare purity percentage has not. That difference is real and it is the difference this rubric measures. Whether it predicts what is in the vial is a separate question that would require independent testing to answer, and the Institute does not perform independent testing.

§2The six criteria

Table 1. The six criteria and their weights. Weights sum to 100.

CriterionWeight, %What it assesses
Certificate-of-analysis completeness25Assessed against the Institute's COA minimum data standard (CEI-MS-14). Full marks require identity by two orthogonal methods, purity by a stability-indicating chromatographic method with the method stated, peptide content, water content, counter-ion identity and content, and batch traceability.
Independent third-party testing record25Frequency, breadth and verifiability of testing by a laboratory independent of the supplier. Reports must be attributable to a named laboratory and a named batch.
Identity confirmation practice15Whether identity is confirmed by an orthogonal method rather than inferred from a single chromatographic retention time, and whether investigational compounds with contested sequences are addressed.
Documentation transparency and consistency15Consistency between published figures, catalogue claims and independent results; willingness to correct; disclosure of what isn't tested.
Storage, packaging and cold-chain evidence10Evidence that storage and shipment conditions are controlled and documented, and that light- and oxidation-sensitive compounds are handled accordingly.
Responsiveness to documented enquiry10Response to the Institute's written enquiries regarding batch documentation, method details and discrepancies. Recorded in each dossier's correspondence log.

§2.1Certificate-of-analysis completeness

Assessed against the Institute's COA minimum data standard (CEI-MS-14). Full marks require identity by two orthogonal methods, purity by a stability-indicating chromatographic method with the method stated, peptide content, water content, counter-ion identity and content, and batch traceability.

Table 2. Anchors for certificate-of-analysis completeness.

PointAnchor
0No certificate, or a certificate with no method information
1Purity percentage only, no method, no batch link
2Purity with method named; no content or counter-ion
3Purity, method and mass-spectrometric identity; content absent
4All critical fields present; one or two recommended fields absent
5Every critical and recommended field present with traceable batch linkage

§2.2Independent third-party testing record

Frequency, breadth and verifiability of testing by a laboratory independent of the supplier. Reports must be attributable to a named laboratory and a named batch.

Table 3. Anchors for independent third-party testing record.

PointAnchor
0No independent testing published
1Isolated reports, batch not identified
2Occasional reports for a small part of the catalogue
3Regular reports across a substantial part of the catalogue
4Systematic per-batch reporting for the principal product lines
5Systematic per-batch reporting across the catalogue with verifiable laboratory attribution

§2.3Identity confirmation practice

Whether identity is confirmed by an orthogonal method rather than inferred from a single chromatographic retention time, and whether investigational compounds with contested sequences are addressed.

Table 4. Anchors for identity confirmation practice.

PointAnchor
0No identity method reported
1Retention time only
2Mass spectrometry reported without resolution or expected-mass statement
3Mass spectrometry with expected mass stated
4High-resolution mass spectrometry with deconvoluted average mass
5Orthogonal identity with sequence confirmation for compounds where the sequence is contested

§2.4Documentation transparency and consistency

Consistency between published figures, catalogue claims and independent results; willingness to correct; disclosure of what isn't tested.

Table 5. Anchors for documentation transparency and consistency.

PointAnchor
0Claims contradicted by independent data with no correction
1Material inconsistencies unresolved
2Minor inconsistencies; no stated correction process
3Consistent documentation; limitations not disclosed
4Consistent documentation with limitations acknowledged
5Consistent documentation, limitations disclosed, and corrections issued when identified

§2.5Storage, packaging and cold-chain evidence

Evidence that storage and shipment conditions are controlled and documented, and that light- and oxidation-sensitive compounds are handled accordingly.

Table 6. Anchors for storage, packaging and cold-chain evidence.

PointAnchor
0No information
1Generic statements only
2Storage conditions stated; shipment uncontrolled
3Cold-chain used for sensitive lines
4Cold-chain documented with excursion handling
5Documented conditions with compound-specific handling including light protection

§2.6Responsiveness to documented enquiry

Response to the Institute's written enquiries regarding batch documentation, method details and discrepancies. Recorded in each dossier's correspondence log.

Table 7. Anchors for responsiveness to documented enquiry.

PointAnchor
0No response to any enquiry
1Response without substantive content
2Partial response after repeated enquiry
3Substantive response within 30 days
4Substantive response within 14 days with documents supplied
5Substantive response within 7 days with documents and method details supplied

§3The three verification states

Table 8. The three states used on every dossier. The distinction between the second and third is the substance of the assessment.

StateMeaning
VerifiedDocumentation supporting the claim was examined by the Institute. Verification is of documentation and never of product.
Not verifiedThe Institute looked for supporting documentation and did not find it. A supplier may hold data it does not publish, and the assessment cannot distinguish an absent determination from an unpublished one.
Not assessedThe Institute did not examine this attribute. Carries no implication about the attribute and is recorded so that it can be told apart from a failed verification.

§4What no score establishes

The rubric, its weights and its anchors were settled through a public comment period and revised through a second consultation on dossier format. Both dispositions are published in full, including the submissions the Institute did not accept.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.